FDA Alert: MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug

This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. May 11, 2020 Company Contact Information Consumers: Lin Leung, MasterPharm, LLC Phone: (866) 630-5600 Email: recall@masterpharm.com…

[...]

Website Operators Warned by FDA/DEA Offered Antibiotics, Cancer & HIV Treatments in Addition to Misbranded Opioids

On September 30th, the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) issued a joint warning to four online networks that were operating a total of ten fake online pharmacy websites. While all four networks were offering misbranded/counterfeit opioid medications such as tramadol and Soma for sale, three of the online networks had marketplaces offering misbranded medications to treat a kaleidoscope of ailments, such as allergies, cancer, smoking, asthma, and infection.

[...]

Canadians Concerned About US Prescription Drug Importation Proposals

John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.

[...]

Keeping The Drug Supply Chain Safe Keeps Patients Safe

In a statement from the U.S. Food and Drug Administration, Commissioner Scott Gottlieb, M.D. discussed the agency’s continuing efforts to combat the spread of illicit opioids and to ensure the security of America’s drug supply chain. Included in their recent efforts, Commissioner Gottlieb noted that the agency has stepped up enforcement and interdiction work at International Mail Facilities and shut down websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid medications to U.S. citizens…

[...]